| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/04/2004 | EP1442025A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 08/04/2004 | EP1442024A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
| 08/04/2004 | EP1442022A2 Polyamide modulators of cox2 transcription |
| 08/04/2004 | EP1442019A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/04/2004 | EP1441772A2 Polymer conjugates of protein kinase c inhibitors |
| 08/04/2004 | EP1441735A1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 08/04/2004 | EP1441734A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 08/04/2004 | EP1441730A1 Hydrazono-malonitriles |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441724A1 Methods of increasing endogenous testosterone levels |
| 08/04/2004 | EP1441720A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system |
| 08/04/2004 | EP1441719A1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors |
| 08/04/2004 | EP1441683A2 Trisubstituted triazine compounds, and methods for making an using the compounds, which have antitubulin activity |
| 08/04/2004 | EP1368403B1 Polymers |
| 08/04/2004 | EP1192131B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives |
| 08/04/2004 | EP1070714B1 Amidine compounds |
| 08/04/2004 | EP0984944B1 Substituted 4-(3-alkenyl-benzoyl)-pyrazoles |
| 08/04/2004 | EP0961618B1 5-Pyrimidinyl-4-yl-Imidazole Derivate zur Behandlung von CSBP/RK/p38 vermittelten Erkrankungen |
| 08/04/2004 | CN1518548A Teterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-Hydroxytryptamine-6-ligands |
| 08/04/2004 | CN1518547A Heterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 08/04/2004 | CN1518543A Pyrazole derivatives and their use as protein kinase inhibitors |
| 08/04/2004 | CN1160349C Pyrazole derivatives and processes for producing the same, and pesticides containing the same as the active ingredient |
| 08/04/2004 | CN1160348C Aryl-{4-fluoro-4-{(2-pyridin-2-YL-ethylamino)-methyl]-piperidin-yl}-methanone derivatives as 5-HT1 receptor antagonists |
| 08/04/2004 | CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use |
| 08/04/2004 | CN1160332C N-aryloxyethylamine derivatives for treatment of depression |
| 08/04/2004 | CN1160071C Use of substiuted 2,4-imidazolidinedione compounds as analgesics |
| 08/03/2004 | US6770668 Pharmaceutically active compounds and methods of use |
| 08/03/2004 | US6770667 N-((imidazolyl)-phenyl)-fluorene-1-carboxamide derivatives; 5-hydroxytryptamine (5-ht) antagonists; psychological, nervous system, eating, brain and sleep disorders |
| 08/03/2004 | US6770666 Fused-ring compounds and use thereof as drugs |
| 08/03/2004 | US6770655 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome. |
| 08/03/2004 | US6770640 1-Carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of MMP-12 |
| 08/03/2004 | US6770638 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 08/03/2004 | US6770597 Benzohydrazide derivatives as herbicides and desiccant compositions containing them |
| 08/03/2004 | CA2127542C Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 07/29/2004 | WO2004063196A1 1,2,4-triazin-3-yl-hydrazine or 5h-1,2,4-triazino’5,6-b!indol-3-yl-hydrazine compounds as inhibitors of bace useful in the treatment of alzheimer |
| 07/29/2004 | WO2004063192A1 Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators |
| 07/29/2004 | WO2004063189A1 Ondansetron forms and processes of making the same |
| 07/29/2004 | WO2004063156A1 Novel indole derivates as fabp-4 inhibitors |
| 07/29/2004 | WO2004062663A1 Use of substituted 2-phenylbenzimidazoles as medicaments |
| 07/29/2004 | WO2004062662A1 Aminoindazole derivatives and use thereof as kinase inhibitors |
| 07/29/2004 | WO2004062613A2 Hiv integrase inhibitors |
| 07/29/2004 | WO2004062609A2 Pyrimidine derivatives as il-8 receptor antagonists |
| 07/29/2004 | WO2004062568A2 Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent |
| 07/29/2004 | WO2004050039A3 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 07/29/2004 | WO2004050024A3 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 07/29/2004 | WO2004033431A3 Hydroxypyrazoles for use against metabolic-related disorders |
| 07/29/2004 | WO2004033422A3 Modulation of anxiety through blockade of anandamide hydrolysis |
| 07/29/2004 | WO2004031401A3 Novel tyrosine kinases inhibitors |
| 07/29/2004 | WO2004014868A8 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 07/29/2004 | WO2004013091A3 4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases |
| 07/29/2004 | WO2003040107A8 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 07/29/2004 | US20040147752 Carbazole derivatives for the treatment of NPY related diseases |
| 07/29/2004 | US20040147748 Increasing insulin secretion; type II diabetes; such as 2-(3-Chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-N-(5-methylsulfanyl-pyrazin-2-yl)-propionamide |
| 07/29/2004 | US20040147742 Multilayer light emitting diodes; charge transfer compounds and hole blocking layer |
| 07/29/2004 | US20040147586 Antiproliferative agents; anticancer agents; glioblastomas; antidiabetic agents; autoimmune disorders; skin disorders; antiarthritic agents; antiinflammatory agents; cardiovascular disorders |
| 07/29/2004 | US20040147580 Therapy for bacteria infections |
| 07/29/2004 | US20040147579 Antiinflammatory agents; antiarthritic agents; antihistamines; respiratory system disorders; glomerulonephitis; inflammatory bowel disorders; Crohn's disease; skin disorders; tumor necrosis factor sensitive disease |
| 07/29/2004 | US20040147577 Heterocyclic compounds |
| 07/29/2004 | US20040147575 Hypotensive agents; cardiovascular disorders |
| 07/29/2004 | US20040147573 Metalloproteinase inhibitors |
| 07/29/2004 | US20040147555 Anticoagulants; brain disorders; blood circulation disorders; myocardial infraction |
| 07/29/2004 | US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 07/29/2004 | US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147511 Prevent premature labor; dymenorrhea |
| 07/29/2004 | US20040147502 Beta lactam compounds and their use as inhibitors of tryptase |
| 07/29/2004 | US20040147456 For therapy and prophylaxis of thrombolytic condition |
| 07/29/2004 | US20040147429 Endogenous, constitutively activated G protein-coupled orphan receptors |
| 07/29/2004 | US20040146438 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 07/29/2004 | US20040143911 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye |
| 07/29/2004 | DE10302020A1 New beta-isoindigo compounds, useful as pigments or dyes in e.g. toners, lacquers, plastics or inks, are obtained by condensation of a bis-isoindolidene-diimine with an alicyclic or heterocyclic compound |
| 07/29/2004 | CA2512813A1 Use of substituted 2-phenylbenzimidazoles as phamaceutical compositions |
| 07/29/2004 | CA2507948A1 Aminoindazole derivates and use thereof as kinase inhibitors |
| 07/28/2004 | EP1440069A1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 07/28/2004 | EP1440066A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 07/28/2004 | EP1440059A1 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists |
| 07/28/2004 | EP1439834A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/28/2004 | EP1176958B1 Novel catechols as antimicrobial agents |
| 07/28/2004 | CN1516690A Heterocyclic derivatives and medicines |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1516587A Quinazoline derivatives capable of promoting release of parathyroid |
| 07/28/2004 | CN1516580A Sulfonamides |
| 07/28/2004 | CN1515563A Aryl substituted piperazine for curing benign prostatauxe |
| 07/28/2004 | CN1515562A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/28/2004 | CN1515559A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/28/2004 | CN1515556A Intermediate compound for preparing aryl substituted piperazine |
| 07/28/2004 | CN1515552A Near infrared fluorescence contrast agent and fluorescence imaging |
| 07/28/2004 | CN1515550A Thrombosis resisting preparation |
| 07/28/2004 | CN1515252A Application of indole derivative as SHTI excitomotor |
| 07/28/2004 | CN1159315C 4,5-pyrrolo-oxindoles |
| 07/28/2004 | CN1159302C Triazine derivatives, their production and use |
| 07/28/2004 | CN1159298C Parasiticidal compound |
| 07/28/2004 | CN1159292C Aryl substitued cyclic amines as selective dopamine D3 ligands |
| 07/27/2004 | US6767915 Substituted piperidines as melanocortin receptor agonists |
| 07/27/2004 | US6767912 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/27/2004 | US6767910 Triazolo[4,5-d]pyrimidinyl compounds |
| 07/27/2004 | US6767909 Cardiovascular disorders; vasoconstriction |
| 07/27/2004 | US6767908 Treatment of cytokine mediated diseases such as arthritis. |
| 07/27/2004 | CA2350089C Indole derivatives |
| 07/27/2004 | CA2118512C Agents for treating substance abuse disorders |